ADMA Biologics Inc (NASDAQ:ADMA)

3.52
Delayed Data
As of Sep 22
 -0.04 / -1.12%
Today’s Change
2.24
Today|||52-Week Range
4.65
-9.28%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +70.45% increase from the last price of 3.52.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$55.9M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.35%
 
 
 
 
 
 
Growthannually 75.00%
 
 
 
 
 
 

Sales

Growthquarterly -6.95%
 
 
 
 
 
 
Growthannually 46.71%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.